FDA effort to regulate old drugs results in price increase

04/12/2010 | Wall Street Journal, The

The FDA's initiative to regulate old, unapproved drugs unintentionally allowed for companies to increase the prices of the products to the same levels as brand-name treatments.

View Full Article in:

Wall Street Journal, The